{"disease":{"id":"bk-virus-nephropathy","name":"bk virus nephropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03719339","title":"VIRTUUS Children's Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":445,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT03216967","title":"Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06219616","title":"Prediction of BK Virus Reactivation in Kidney Transplant Recipient","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"King Chulalongkorn Memorial Hospital","has_results":false},{"nct_id":"NCT04605484","title":"Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT05026021","title":"Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia","phase":"","overall_status":"UNKNOWN","enrollment_count":41,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05358106","title":"Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Memo Therapeutics AG","has_results":false},{"nct_id":"NCT05511779","title":"Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"SymBio Pharmaceuticals","has_results":false},{"nct_id":"NCT03456999","title":"Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}